Turku University Hospital, Dept of Paediatrics
Welcome,         Profile    Billing    Logout  
 0 Trials 
4 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lähteenmäki, Päivi
ALLTogether1, NCT04307576 / 2018-001795-38: A Treatment Study Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
3
6430
Europe, RoW
Omitted Doxorubicin, Omitted Vincristine+Dexamethasone pulses, Inotuzumab Ozogamicin+Standard Maintenance Therapy, Besponsa+Maintenance Therapy, Imatinib, 6-tioguanine+Standard Maintenance Therapy, Blinatumomab, Blincyto
Mats Heyman, The Swedish Research Council, The Swedish Childhood Cancer Foundation, Pfizer, Servier, NordForsk, Aamu Pediatric Cancer Foundation, German Society for Pediatric Oncology and Hematology GPOH gGmbH, Clinical Trial Center North (CTC North GmbH & Co. KG), Belgium Health Care Knowledge Centre, Karolinska Institutet, Cancer Research UK, Fundação Rui Osório de Castro, Acreditar - Associação de Pais e Amigos das Crianças com Cancro, Grupo Português De Leucemias Pediátricas, Amgen, Nova Laboratories Limited, Danish Child Cancer Foundation, Danish Cancer Society, The Novo Nordic Foundation, Assistance Publique - Hôpitaux de Paris, Direction Générale de l'Offre de Soins
Leukemia, Acute Lymphoblastic
06/27
06/32
NCT03590171: International Study for Treatment of High Risk Childhood Relapsed ALL 2010

Recruiting
2
250
Europe, RoW
Bortezomib
Charite University, Berlin, Germany, Australian & New Zealand Children's Haematology/Oncology Group, St. Anna Kinderkrebsforschung, CCRI (co-sponsor, Austria), European Organisation for Research and Treatment of Cancer - EORTC, University Hospital Motol (Co-Sponsor Czech Republic), Copenhagen University Hospital, Rigshospitalet (co-sponsor, Denmark), Turku University Central Hospital (co-sponsor, Finland), Centre Hospitalier Universitaire de Nice, Our Lady's Chilrden's Hospital (Co-Sponsor Ireland), Tel Aviv Sourasky Medical Centre (Co-Sponsor Israel), Ospedale Pediatrico Bambino (co-sponsor, Italy), Prinses Máxima Centrum (Co-Sponsor Netherlands), Oslo University Hospital (co-sponsor, Norway), Medical University of Wroclaw (Co-Sponsor Poland), Instituto Português de Oncologia de Lisboa (co-sponsor, Portugal), Karolinska University Hospital Stockholm (co-sponsor, Sweden), Spanish Society of Pediatric Hematology and Oncology (SEHOP) (Co-Sponsor Spain), University Children's Hospital, Zurich, Central Manchester University Hospitals NHS Foundation Trust (co-sponsor, UK)
Acute Lymphoblastic Leukemia (ALL)
12/27
12/27
NCT02300766: Cerebellar Mutism Syndrome Study

Recruiting
N/A
1000
Europe, RoW
Rigshospitalet, Denmark, Odense University Hospital, Aarhus University Hospital, Aalborg University Hospital, Technical University of Denmark, Karolinska University Hospital, Skane University Hospital, University Hospital, Linkoeping, Uppsala University Hospital, Sahlgrenska University Hospital, Sweden, University Hospital, Umeå, Oslo University Hospital, Trondheim University Hospital, Haukeland University Hospital, University Hospital of North Norway, Helsinki University Central Hospital, Tampere University Hospital, Kuopio University Hospital, Turku University Hospital, Oulu University Hospital, Radboud University Medical Center, Liverpool University Hospitals NHS Foundation Trust, Great Ormond Street Hospital for Children NHS Foundation Trust, Nottingham University Hospitals NHS Trust, University Hospital Birmingham, University Hospitals Bristol and Weston NHS Foundation Trust, Royal Infirmary of Edinburgh, South Glasgow University Hospitals NHS Trust, University Hospital Tuebingen, Medical University of Vienna, Ospedale Pediatrico Bambin Gesù, Motol University Hospital, University of Leipzig Medical Center, Universitaire Ziekenhuizen KU Leuven, Queen Fabiola Children's University Hospital, Cliniques universitaires Saint-Luc, University Hospital, Ghent, Hospital De La Citadelle, CHC MontLégia, University Hospital, Antwerp
Infratentorial Neoplasms, Mutism
12/28
12/28
NCT03911128: A Treatment Protocol for Participants 0-45 Years With Acute Lymphoblastic Leukaemia

Recruiting
N/A
500
Europe, RoW
Observational
Mats Heyman, Nordic Society for Pediatric Hematology and Oncology, The Swedish Childhood Cancer Foundation, NordForsk
Leukemia, Acute Lymphoblastic
08/28
08/30

Download Options